BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2093934)

  • 1. [The effect of various extracts of Ginkgo biloba on the response of lysosomes to free radicals and to osmotic shock].
    Wattiaux R; Dubois F; Wattiaux-De Coninck S
    Phlebologie; 1990; 43(4):753-61. PubMed ID: 2093934
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of various flavonoids on lysosomes subjected to an oxidative or an osmotic stress.
    Decharneux T; Dubois F; Beauloye C; Wattiaux-De Coninck S; Wattiaux R
    Biochem Pharmacol; 1992 Oct; 44(7):1243-8. PubMed ID: 1417948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective responses of three Ginkgo biloba leaf-derived constituents on human intestinal bacteria.
    Lee HS; Kim MJ
    J Agric Food Chem; 2002 Mar; 50(7):1840-4. PubMed ID: 11902921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of extracts of Ginkgo biloba and its constituents on the fibrillogenesis and on the stability of collagen fibrils in vitro].
    Herbage D; Willems R; Flandin F
    Phlebologie; 1991; 44(4):873-80. PubMed ID: 1666679
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: role of ginkgolides, bilobalide, and flavonols.
    Kuo If; Chen J; Chang TK
    Can J Physiol Pharmacol; 2004 Jan; 82(1):57-64. PubMed ID: 15052306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ginkgo--myth and reality].
    Z'Brun A
    Praxis (Bern 1994); 1995 Jan; 84(1):1-6. PubMed ID: 7839037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginkgo biloba.
    Altern Med Rev; 1998 Feb; 3(1):54-7. PubMed ID: 9600026
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginkgo biloba extract EGb 761 and isolated ginkgolides.
    Amri H; Ogwuegbu SO; Boujrad N; Drieu K; Papadopoulos V
    Endocrinology; 1996 Dec; 137(12):5707-18. PubMed ID: 8940403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids.
    Mohamed MF; Frye RF
    Drug Metab Dispos; 2010 Feb; 38(2):270-5. PubMed ID: 19889883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Superoxide dismutase activity of Ginkgo biloba extract].
    Diwok M; Kuklinski B; Ernst B
    Z Gesamte Inn Med; 1992 Jul; 47(7):308-11. PubMed ID: 1496840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of Ginkgo biloba extracts.
    Biber A
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S32-7. PubMed ID: 13130386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Ginkgo Folium on antitumor: Bioactive constituents and the potential mechanism.
    Hu D; Wang HJ; Yu LH; Guan ZR; Jiang YP; Hu JH; Yan YX; Zhou ZH; Lou JS
    J Ethnopharmacol; 2024 Mar; 321():117202. PubMed ID: 37742878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes.
    Chang TK; Chen J; Teng XW
    Drug Metab Dispos; 2006 Feb; 34(2):234-42. PubMed ID: 16258077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory Aromatase Effects of Flavonoids from Ginkgo Biloba Extracts on Estrogen Biosynthesis.
    Park YJ; Choo WH; Kim HR; Chung KH; Oh SM
    Asian Pac J Cancer Prev; 2015; 16(15):6317-25. PubMed ID: 26434836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-antioxidant activity relationships of flavonoids: a re-examination.
    Silva MM; Santos MR; Caroço G; Rocha R; Justino G; Mira L
    Free Radic Res; 2002 Nov; 36(11):1219-27. PubMed ID: 12592674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
    van Acker SA; Boven E; Kuiper K; van den Berg DJ; Grimbergen JA; Kramer K; Bast A; van der Vijgh WJ
    Clin Cancer Res; 1997 Oct; 3(10):1747-54. PubMed ID: 9815559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidence.
    Ye B; Aponte M; Dai Y; Li L; Ho MC; Vitonis A; Edwards D; Huang TN; Cramer DW
    Cancer Lett; 2007 Jun; 251(1):43-52. PubMed ID: 17194528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons.
    Oyama Y; Fuchs PA; Katayama N; Noda K
    Brain Res; 1994 Jan; 635(1-2):125-9. PubMed ID: 8173947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L.
    Braquet P
    Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():179-98. PubMed ID: 2949548
    [No Abstract]   [Full Text] [Related]  

  • 20. Antioxidant compounds EGB-761 and BN-520 21 attenuate heat shock protein (HSP 72 kD) response, edema and cell changes following hyperthermic brain injury. An experimental study using immunohistochemistry in the rat.
    Westman J; Drieu K; Sharma HS
    Amino Acids; 2000; 19(1):339-50. PubMed ID: 11026505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.